Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.0043 | 1 |
mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.0042 | 1 |